The efficiency of 48-week treatment with lopinavir/ritonavir in combination with lamivudin in HIV-1-infected patients in the routine clinical settings of the Russian Federation: results of a prospective, multicenter, observational study (the SIMPLE study)
Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy · 2018
DOI: 10.18565/epidem.2018.2.56-64 ↗Kurz gefasst
Fachartikel in der Zeitschrift Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy, 2018. Verfasst von Orlova-Morozova E.A. Orlova-Morozova und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Orlova-Morozova, O. E., Plotnikova, P. Y., Pokrovskaya, P. A., Radzikhovskaya, R. M., N, S. N. S., Nagimova, N. F., S, M. S. M., Wegzyn, W. C., Dorr, D. P., Potapov, P. A., & Kruglova, K. A. (2018). The efficiency of 48-week treatment with lopinavir/ritonavir in combination with lamivudin in HIV-1-infected patients in the routine clinical settings of the Russian Federation: results of a prospective, multicenter, observational study (the SIMPLE study). Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. https://doi.org/10.18565/epidem.2018.2.56-64
Vancouver
Orlova-Morozova OE, Plotnikova PY, Pokrovskaya PA, Radzikhovskaya RM, N SNS, Nagimova NF, et al. The efficiency of 48-week treatment with lopinavir/ritonavir in combination with lamivudin in HIV-1-infected patients in the routine clinical settings of the Russian Federation: results of a prospective, multicenter, observational study (the SIMPLE study). Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. 2018. doi:10.18565/epidem.2018.2.56-64
BibTeX
@article{OrlovaMorozova2018,
author = {Orlova-Morozova, Orlova-Morozova E.A. and Plotnikova, Plotnikova Yu.K. and Pokrovskaya, Pokrovskaya A.V. and Radzikhovskaya, Radzikhovskaya M.V. and N, Sizova N.V. Sizova and Nagimova, Nagimova F.I. and S, Mikhailov S.P. Mikhailov and Wegzyn, Wegzyn C.M. and Dorr, Dorr P.K. and Potapov, Potapov A.V. and Kruglova, Kruglova A.I.},
title = {The efficiency of 48-week treatment with lopinavir/ritonavir in combination with lamivudin in HIV-1-infected patients in the routine clinical settings of the Russian Federation: results of a prospective, multicenter, observational study (the SIMPLE study)},
journal = {Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy},
year = {2018},
doi = {10.18565/epidem.2018.2.56-64}
}
EUVIMED